ATE493970T1 - Konservierungsmittelfreie augenlösung auf prostaglandin-basis - Google Patents
Konservierungsmittelfreie augenlösung auf prostaglandin-basisInfo
- Publication number
- ATE493970T1 ATE493970T1 AT08826597T AT08826597T ATE493970T1 AT E493970 T1 ATE493970 T1 AT E493970T1 AT 08826597 T AT08826597 T AT 08826597T AT 08826597 T AT08826597 T AT 08826597T AT E493970 T1 ATE493970 T1 AT E493970T1
- Authority
- AT
- Austria
- Prior art keywords
- prostaglandin
- preservative
- solution based
- free eye
- eye solution
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 229940072106 hydroxystearate Drugs 0.000 abstract 1
- 229940054534 ophthalmic solution Drugs 0.000 abstract 1
- 239000002997 ophthalmic solution Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705272A FR2918891B1 (fr) | 2007-07-20 | 2007-07-20 | Solution ophtalmique a base de prostaglandines sans conservateur |
| PCT/FR2008/051347 WO2009013435A2 (fr) | 2007-07-20 | 2008-07-17 | Solution ophtalmique à base de prostaglandines sans conservateur |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE493970T1 true ATE493970T1 (de) | 2011-01-15 |
Family
ID=39047927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08826597T ATE493970T1 (de) | 2007-07-20 | 2008-07-17 | Konservierungsmittelfreie augenlösung auf prostaglandin-basis |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8772337B2 (de) |
| EP (1) | EP2178504B1 (de) |
| AT (1) | ATE493970T1 (de) |
| DE (1) | DE602008004356D1 (de) |
| ES (1) | ES2355018T3 (de) |
| FR (1) | FR2918891B1 (de) |
| PL (1) | PL2178504T3 (de) |
| PT (1) | PT2178504E (de) |
| WO (1) | WO2009013435A2 (de) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2197449A4 (de) * | 2007-10-16 | 2013-10-09 | Sun Pharma Advanced Res Co Ltd | Neuartige ophthalmische zusammensetzungen |
| EP2127638A1 (de) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom |
| ES2564502T3 (es) | 2010-03-17 | 2016-03-23 | Novaliq Gmbh | Composición farmacéutica para el tratamiento de la presión intraocular aumentada |
| CA2798923A1 (en) * | 2010-05-07 | 2011-11-10 | Sun Pharma Advanced Research Company Ltd. | Novel ophthalmic compositions |
| FR2961694B1 (fr) * | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| ES2708451T3 (es) * | 2010-07-29 | 2019-04-09 | Allergan Inc | Soluciones de bimatoprost y timolol sin conservantes |
| US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| AU2011282679A1 (en) * | 2010-07-29 | 2013-03-07 | Allergan, Inc. | Preservative free bimatoprost solutions |
| EP2444063A1 (de) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Flüssige pharmazeutische Zusammensetzungen zur Abgabe von Wirkstoffen |
| EP2452669A1 (de) | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmische Zusammensetzung |
| EP2462921A1 (de) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Flüssige pharmazeutische Zusammensetzungen zur Behandlung einer Erkrankung der Hinterseite des Auges |
| CN103596572A (zh) * | 2011-04-12 | 2014-02-19 | 株式会社·R-技术上野 | 水性眼用组合物 |
| JP2014515383A (ja) * | 2011-05-27 | 2014-06-30 | レイショファーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | PGF2α類似体を含む眼科用製剤 |
| DE202013012753U1 (de) | 2012-09-12 | 2019-03-04 | Novaliq Gmbh | Zusammensetzungen semifluorierter Alkane zur Verwendung in der Behandlung von Keratoconjunctivitis Sicca |
| MX360469B (es) | 2012-09-12 | 2018-11-05 | Novaliq Gmbh | Composiciones que comprenden mezclas de alcanos semifluorados. |
| IN2013MU02015A (de) * | 2013-06-13 | 2015-07-10 | Cipla Ltd | |
| US10350161B2 (en) | 2013-10-15 | 2019-07-16 | Pharmathen S.A. | Preservative free pharmaceutical compositions for ophthalmic administration |
| GR1008330B (el) * | 2013-10-17 | 2014-10-20 | "Φαρματεν Α.Β.Ε.Ε.", | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση εχoν βελτιωμενες φυσικες ιδιοτητες και ογκο σταγονας |
| GR1008483B (el) * | 2013-12-23 | 2015-05-12 | Rafarm Α.Ε.Β.Ε., | Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης |
| CN105012231A (zh) * | 2014-04-30 | 2015-11-04 | 四川科伦药物研究院有限公司 | 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法 |
| JP5893204B1 (ja) * | 2015-02-23 | 2016-03-23 | 参天製薬株式会社 | 防腐効果のある医薬の組合せ |
| EP3103439B1 (de) * | 2015-06-09 | 2019-08-07 | MEDproject Pharma-Entwicklungs- und Vertriebsgesellschaft mbH | Tropfbares ophthalmisches bimatoprostgel |
| ES2953837T3 (es) | 2015-09-30 | 2023-11-16 | Novaliq Gmbh | 2-perfluorobutil pentano para administración oftálmica |
| CN120884568A (zh) | 2015-09-30 | 2025-11-04 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| GR1008921B (el) * | 2015-12-10 | 2017-01-12 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον δεξαμεθαζονη |
| GR1009040B (el) | 2016-04-19 | 2017-05-19 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου |
| EP3442480B1 (de) | 2016-06-23 | 2019-10-02 | Novaliq GmbH | Verfahren zur topischen verabreichung |
| TWI814709B (zh) * | 2016-08-23 | 2023-09-11 | 日商大塚製藥股份有限公司 | 保存效果或光穩定性經改善之眼科藥用組成物 |
| US11684589B2 (en) | 2016-09-22 | 2023-06-27 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| JP6869336B2 (ja) | 2016-09-23 | 2021-05-12 | ノバリック ゲーエムベーハー | シクロスポリンを含む眼科用組成物 |
| KR101770324B1 (ko) * | 2016-11-09 | 2017-08-22 | 주식회사태준제약 | 안압 강하용 점안 조성물 |
| DK3399962T3 (da) | 2016-12-23 | 2020-09-07 | Novaliq Gmbh | Oftalmisk sammensætning til behandling af tør øjensygdom |
| MX388460B (es) | 2017-04-21 | 2025-03-20 | Dermaliq Therapeutics Inc | Composiciones de yodo. |
| CN110650734B (zh) | 2017-05-12 | 2024-11-15 | 诺瓦利克有限责任公司 | 治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物 |
| IL273531B2 (en) | 2017-09-27 | 2024-05-01 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
| EP3758676A1 (de) | 2018-03-02 | 2021-01-06 | Novaliq GmbH | Pharmazeutische zusammensetzungen mit nebivolol |
| JP2021522219A (ja) | 2018-04-27 | 2021-08-30 | ノバリック ゲーエムベーハー | 緑内障の治療のためのタフルプロストを含む眼科用組成物 |
| TWI839364B (zh) | 2018-07-12 | 2024-04-21 | 法國商尼可斯股份有限公司 | 包含釋放一氧化氮的前列醯胺之眼用組成物 |
| WO2020074697A1 (en) | 2018-10-12 | 2020-04-16 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| WO2020165132A1 (en) | 2019-02-13 | 2020-08-20 | Novaliq Gmbh | Compositions and methods for the treatment of ocular neovascularization |
| US12539302B2 (en) | 2019-08-07 | 2026-02-03 | Aneira Pharma, Inc. | Methods and compositions for the treatment of hair loss |
| US12226415B2 (en) | 2019-08-07 | 2025-02-18 | Aneira Pharma, Inc. | Methods and compositions for the treatment of hair loss |
| WO2021044045A1 (en) | 2019-09-06 | 2021-03-11 | Novaliq Gmbh | Ophthalmic composition for the treatment of uveitis |
| US11400100B2 (en) | 2019-12-11 | 2022-08-02 | Somerset Therapeutics, Llc. | Effective benzalkonium chloride-free bimatoprost ophthalmic compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431833A (en) * | 1982-12-27 | 1984-02-14 | American Cyanamid Company | Prostaglandin and hydroxylated fatty acid ester formulations |
| HU207222B (en) * | 1990-02-15 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing eyedrops containing primycin |
| JP3480549B2 (ja) * | 1996-12-26 | 2003-12-22 | 参天製薬株式会社 | ジフルオロプロスタグランジン誘導体およびその用途 |
| US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
| US20060199863A1 (en) * | 2003-07-31 | 2006-09-07 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
| AR063111A1 (es) * | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
-
2007
- 2007-07-20 FR FR0705272A patent/FR2918891B1/fr not_active Expired - Fee Related
-
2008
- 2008-07-17 US US12/666,778 patent/US8772337B2/en active Active
- 2008-07-17 PT PT08826597T patent/PT2178504E/pt unknown
- 2008-07-17 ES ES08826597T patent/ES2355018T3/es active Active
- 2008-07-17 DE DE602008004356T patent/DE602008004356D1/de active Active
- 2008-07-17 AT AT08826597T patent/ATE493970T1/de active
- 2008-07-17 EP EP08826597A patent/EP2178504B1/de active Active
- 2008-07-17 PL PL08826597T patent/PL2178504T3/pl unknown
- 2008-07-17 WO PCT/FR2008/051347 patent/WO2009013435A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US8772337B2 (en) | 2014-07-08 |
| DE602008004356D1 (de) | 2011-02-17 |
| WO2009013435A2 (fr) | 2009-01-29 |
| PL2178504T3 (pl) | 2011-06-30 |
| ES2355018T3 (es) | 2011-03-22 |
| EP2178504A2 (de) | 2010-04-28 |
| US20100210720A1 (en) | 2010-08-19 |
| EP2178504B1 (de) | 2011-01-05 |
| PT2178504E (pt) | 2011-01-31 |
| FR2918891B1 (fr) | 2009-09-25 |
| WO2009013435A3 (fr) | 2009-03-12 |
| FR2918891A1 (fr) | 2009-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE493970T1 (de) | Konservierungsmittelfreie augenlösung auf prostaglandin-basis | |
| CY1119467T1 (el) | Ζιζανιοκτονες συνθεσεις που περιεχουν λιμονενιο | |
| CR20110043A (es) | Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilidas sustituidas | |
| MX2010002930A (es) | Formulaciones que comprenden una composicion anti-microbiana. | |
| CR11747A (es) | Microemulsion mejorada que tiene un amplio rango de aplicacion | |
| BR112015014562A2 (pt) | composições pesticidas e processos com estas relacionados | |
| SV2009003392A (es) | Aril pirrolidinas insecticidas | |
| AU2009296340B2 (en) | Glyphosate formulations containing amidoalkylamine surfactants | |
| BR112015023391A2 (pt) | formulações compreendendo conjugado droga-anticorpo anti-egfr | |
| CO6660508A2 (es) | Sistema polimérico para suministrar una solución no viscosa a base de prostaglandina, sin conservadores | |
| BR112014019372A8 (pt) | Formulação, e, método de obtenção de uma formulação | |
| CR10578A (es) | Concentrados no acuosos de principios activos con efecto herbicida | |
| CL2010001620A1 (es) | Composicion agricola, del cuidado personal, del cuidado de la casa y de revestimiento que comprende silicona y otro componente adicional; emulsion acuosa y no acuosa que comprende la composicion agricola; y metodo para formular dichas composiciones (div. sol. n° 656-207). | |
| CR20110190A (es) | Agente rodenticida sinérgico | |
| UY30790A1 (es) | Combinacion de dos agentes antiparasitarios, en particular un derivado de 1-aril-4-ciclopropilpirazol y un agente antihelmintico y aplicaciones | |
| MX385380B (es) | Formulacion topica para promover la curacion de heridas. | |
| MX2011008756A (es) | Composicion insecticida que comprende un derivado de hidracida antranilica y un neonicotinoide. | |
| EA201391463A1 (ru) | Жидкая инсектицидная композиция | |
| EA201301332A1 (ru) | ОФТАЛЬМОЛОГИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ АНАЛОГ PGF2α | |
| ECSP088476A (es) | Combinación de productos activos fungicidas | |
| BR112013009415A2 (pt) | composto de éter arilóxidihalo-propenil e uso destes | |
| CR20130520A (es) | Composición herbicida que comprende flazasulfuron y metribuzina | |
| PL408073A1 (pl) | Chwastobójczy koncentrat zawiesinowy | |
| PE20211897A1 (es) | Mezclas insecticidas de bifentrina y clorantraniliprol | |
| DOP2021000032A (es) | Composición agroquímica estable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2178504 Country of ref document: EP |